{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:04Z","timestamp":1746331624852},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T00:00:00Z","timestamp":1230163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s12185-008-0229-6","type":"journal-article","created":{"date-parts":[[2008,12,24]],"date-time":"2008-12-24T01:35:20Z","timestamp":1230082520000},"page":"135-138","source":"Crossref","is-referenced-by-count":5,"title":["Hepatitis B virus reactivation during combined therapy with deferiprone and desferioxamine in a hepatitis B surface antigen thalassemic carrier"],"prefix":"10.1007","volume":"89","author":[{"given":"Paolo","family":"Ricchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Lanza Galeota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Di Matola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Ammirabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Prossomariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,25]]},"reference":[{"key":"229_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.21051","volume":"43","author":"W Yeo","year":"2006","unstructured":"Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43:209\u201320. doi:\n                    10.1002\/hep.21051\n                    \n                  .","journal-title":"Hepatology"},{"key":"229_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","volume":"103","author":"B Wonke","year":"1998","unstructured":"Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol. 1998;103:361\u2013644. doi:\n                    10.1046\/j.1365-2141.1998.01002.x\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"229_CR3","first-page":"1163","volume":"90","author":"R Origa","year":"2005","unstructured":"Origa R, Bina P, Agus A, Crobu G, Defraia E, Dess\u00ec C, et al. Combined therapy with deferiprone and desfoerrioxamine in thalassemia major. Haematologica. 2005;90:1163\u20138.","journal-title":"Haematologica"},{"key":"229_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","volume":"360","author":"LJ Anderson","year":"2002","unstructured":"Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subsutaneous desferrioxamine on myocardial iron concentrations and ventricular function in \u03b2-thalassaemia. Lancet. 2002;360:516\u201320. doi:\n                    10.1016\/S0140-6736(02)09740-4\n                    \n                  .","journal-title":"Lancet"},{"key":"229_CR5","first-page":"489","volume":"88","author":"A Piga","year":"2003","unstructured":"Piga A, Gaglioti C, Fogliacco E, Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica. 2003;88:489\u201396.","journal-title":"Haematologica"},{"key":"229_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00277-005-0075-z","volume":"85","author":"S Daar","year":"2006","unstructured":"Daar S, Pathare AV. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol. 2006;85:315\u20139. doi:\n                    10.1007\/s00277-005-0075-z\n                    \n                  .","journal-title":"Ann Hematol"},{"key":"229_CR7","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","volume":"115","author":"MA Tanner","year":"2007","unstructured":"Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115:1876\u201384. doi:\n                    10.1161\/CIRCULATIONAHA.106.648790\n                    \n                  .","journal-title":"Circulation"},{"key":"229_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.04240.x","volume":"121","author":"FH Mourad","year":"2003","unstructured":"Mourad FH, Hoffbrand AV, Sheikh-Taha M, Koussa S, Khoriaty AI, Taher A. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol. 2003;121:187\u20139. doi:\n                    10.1046\/j.1365-2141.2003.04240.x\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"229_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.thj.6200550","volume":"5","author":"V Alymara","year":"2004","unstructured":"Alymara V, Bourantas D, Chaidos A, Bouranta P, Gouva M, Vassou A, et al. Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone. Hematol J. 2004;5:475\u20139. doi:\n                    10.1038\/sj.thj.6200550\n                    \n                  .","journal-title":"Hematol J"},{"key":"229_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1046\/j.0902-4441.2004.00180.x","volume":"72","author":"U Heider","year":"2004","unstructured":"Heider U, Fleissner C, Zavrski I, Jakob C, Dietzel T, Eucker J, et al. Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection. Eur J Haematol. 2004;72:64\u20136. doi:\n                    10.1046\/j.0902-4441.2004.00180.x\n                    \n                  .","journal-title":"Eur J Haematol"},{"key":"229_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0609.2004.00375.x","volume":"74","author":"E Iannitto","year":"2005","unstructured":"Iannitto E, Minardi V, Calvaruso G, Mul\u00e8 A, Ammatuna E, Di Trapani R, et al. Hepatitis B virus reactivation and alemtuzumab therapy. Eur J Haematol. 2005;74:254\u20138. doi:\n                    10.1111\/j.1600-0609.2004.00375.x\n                    \n                  .","journal-title":"Eur J Haematol"},{"key":"229_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1046\/j.1365-2141.1997.d01-2014.x","volume":"96","author":"A Castriota-Scanderbeg","year":"1997","unstructured":"Castriota-Scanderbeg A, Sacco M. Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone). Br J Haematol. 1997;96:254\u20135. doi:\n                    10.1046\/j.1365-2141.1997.d01-2014.x\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"229_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1365-2141.1997.2463064.x","volume":"98","author":"R Loebstein","year":"1997","unstructured":"Loebstein R, Dalal I, Nisbet-Brown E, Berkovitch M, Meydan N, Andrews D, et al. Immune function in patients with beta thalassaemia receiving the orally active iron-chelating agent deferiprone. Br J Haematol. 1997;98:597\u2013600. doi:\n                    10.1046\/j.1365-2141.1997.2463064.x\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"229_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000074235","volume":"110","author":"M Athanassiou-Metaxa","year":"2003","unstructured":"Athanassiou-Metaxa M, Tzimouli V, Economou M, Taparkou A, Tourkantoni N, Kanakoudi-Tsakalidou F. Immune status of thalassemic patients receiving deferiprone or combined deferiprone and desferrioxamine chelation treatment. Acta Haematol. 2003;110:224\u20136. doi:\n                    10.1159\/000074235\n                    \n                  .","journal-title":"Acta Haematol"},{"key":"229_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2006.06082.x","volume":"133","author":"G Rahav","year":"2006","unstructured":"Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz EA, Goldfarb A. Severe infections in thalassaemic patients: prevalence and predisposing factors. Br J Haematol. 2006;133:667\u201374. doi:\n                    10.1111\/j.1365-2141.2006.06082.x\n                    \n                  .","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0229-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0229-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:23Z","timestamp":1559451683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0229-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,25]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0229-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,25]]}}}